Parallax Volatility Advisers
ASND icon

Parallax Volatility Advisers’s Ascendis Pharma A/S ASND Stock Holding History

Parallax Volatility Advisers’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24,788
Closed -$4.13M – 3235
2020
Q4 		$4.13M Buy
+24,788
New +$4.1M ﹤0.01% 1522
2019
Q2 		– Sell
-980
Closed -$115K – 2536
2019
Q1 		$115K Buy
+980
New +$85.8K ﹤0.01% 2085

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Parallax Volatility Advisers's ASND Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of Ascendis Pharma A/S (ASND) in Q1 2021, closing a stake of 24,788 shares — an estimated $4.13M sold.

Parallax Volatility Advisers first reported a position in ASND in Q1 2019 and held it in 2 quarters. The position peaked at $4.13M in Q4 2020. 177 funds tracked by Wall St. Rank hold ASND as of Q1 2021.

  • Parallax Volatility Advisers reported no remaining Ascendis Pharma A/S position as of Q1 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 24,788 Ascendis Pharma A/S shares in Q1 2021, an estimated $4.13M.
  • Parallax Volatility Advisers first reported a position in Ascendis Pharma A/S in Q1 2019 and held it in 2 quarters.
  • Parallax Volatility Advisers's Ascendis Pharma A/S position peaked at $4.13M in Q4 2020.
  • 177 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.